IRIS
POMPILIO, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.907
EU - Europa 3.195
AS - Asia 2.881
SA - Sud America 366
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 11.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.817
SG - Singapore 1.207
CN - Cina 902
IT - Italia 695
IE - Irlanda 528
GB - Regno Unito 413
SE - Svezia 395
UA - Ucraina 392
BR - Brasile 311
TR - Turchia 290
FR - Francia 201
DE - Germania 194
IN - India 137
VN - Vietnam 131
RU - Federazione Russa 96
FI - Finlandia 88
CA - Canada 49
HK - Hong Kong 41
JP - Giappone 38
AT - Austria 34
ES - Italia 33
BD - Bangladesh 27
MX - Messico 27
PL - Polonia 27
NL - Olanda 24
ZA - Sudafrica 23
AR - Argentina 17
BE - Belgio 17
KR - Corea 16
IQ - Iraq 15
CH - Svizzera 14
EC - Ecuador 13
CZ - Repubblica Ceca 12
ID - Indonesia 8
IR - Iran 8
CO - Colombia 7
EU - Europa 7
IL - Israele 7
KE - Kenya 7
LB - Libano 7
LT - Lituania 7
MA - Marocco 7
UZ - Uzbekistan 7
PY - Paraguay 6
SA - Arabia Saudita 6
VE - Venezuela 6
MY - Malesia 5
PK - Pakistan 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
RS - Serbia 4
BY - Bielorussia 3
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
PA - Panama 3
PE - Perù 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
HN - Honduras 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BH - Bahrain 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 11.408
Salva come PNG Salva come JPEG
Città #
Singapore 882
Chandler 835
Jacksonville 551
Dublin 523
Dallas 315
Ashburn 307
Dearborn 281
Beijing 263
Princeton 252
Southend 208
Chieti 162
Nanjing 148
Izmir 142
Los Angeles 133
Santa Clara 103
Wilmington 95
The Dalles 90
Ann Arbor 79
Cambridge 74
New York 73
Altamura 68
Tongling 58
Buffalo 55
Pescara 55
Nanchang 48
Boardman 47
Dong Ket 42
Munich 41
Redondo Beach 41
Hong Kong 40
São Paulo 39
Washington 39
Ho Chi Minh City 38
Vienna 30
Rome 28
Tokyo 27
Kunming 26
Hebei 25
Hefei 24
Shenyang 24
Jiaxing 22
Norwalk 22
Warsaw 22
Milan 21
Montreal 21
Woodbridge 21
Nuremberg 20
Tianjin 20
Chicago 19
Brooklyn 18
Hanoi 17
Johannesburg 17
Brussels 16
Ancona 15
Teramo 15
Amsterdam 14
Houston 14
Stockholm 14
Atlanta 13
Boston 13
Moscow 13
Orem 13
Phoenix 13
Pune 13
Ankara 12
Denver 12
Falls Church 12
Poplar 12
Council Bluffs 11
San Francisco 11
Shanghai 11
Changsha 10
Chennai 10
Civitanova Marche 10
Kocaeli 10
Palermo 10
Seattle 10
Augusta 9
Frankfurt am Main 9
Helsinki 9
Mexico City 9
Mumbai 9
Seoul 9
Toronto 9
Varallo 9
Guangzhou 8
London 8
Rio de Janeiro 8
Belo Horizonte 7
Ferrara 7
Grevenbroich 7
Jinan 7
Nairobi 7
Orange 7
Vittuone 7
Zhengzhou 7
Ascoli Piceno 6
Brasília 6
Brno 6
Ciudad de Villa de Álvarez 6
Totale 7.034
Salva come PNG Salva come JPEG
Nome #
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 208
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 160
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 151
Colonic adenoma-associated Escherichia coli express specific phenotypes 135
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 131
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 130
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 129
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 127
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 126
null 125
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 124
In vitro microbiology studies on a new peritoneal dialysis connector 120
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 118
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 116
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 116
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 116
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 115
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 115
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 114
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 113
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 112
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 112
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 107
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 107
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 106
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 106
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 105
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 104
Normal breathing releases SARS-CoV-2 into the air 104
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 102
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 102
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 101
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 101
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 101
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 101
Hafnia alvei from the farm to the delivery room 101
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 100
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 100
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 100
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 99
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 98
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 97
A cystic fibrosis child with lung function decline 97
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 97
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 97
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 95
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 95
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 95
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 95
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 95
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 95
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 94
Isolation of colistin-resistant Hafnia alvei. 94
Factors associated with adherence to and biofilm formation on polystyrene byStenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. 93
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 93
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 93
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 92
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 92
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 91
Molecular genotyping, adhesion and biofilm formation in methicillin-resistant Staphylococcus aureus clinical strains. 90
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. 89
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 89
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 89
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. 88
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 88
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 88
null 87
V240H replacement, by site-directed mutagenesis, increases resistance toward carbapenems in TEM-149 ESBL producing E. coli. 87
Antidiabetic “gliptins” affect biofilm formation by Streptococcus mutans 87
Multidrug-resistant Geotrichum capitatum from a haematology ward. 86
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 86
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 85
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 84
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 84
Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia. 84
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy 83
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects 83
Patogenesi in fibrosi cistica: clearance di Stenotrophomonas maltophilia ed infiammazione in un modello murino di infezione polmonare. 82
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. 81
In vitro bactericidal and anti-biofilm activity of bovine myeloid antimicrobial peptides against multidrug-resistant bacteria from patients with cystic fibrosis. 81
Ruolo epidemiologico del biofilm in isolati di Stenotrophomonas maltophilia da pazienti con fibrosi cistica e da pazienti ricoverati in unità di terapia intensiva 81
Attvità antibatterica ed anti-biofilm del peptide P19(9/B) verso isolati multi-resistenti isolati da pazienti affetti da fibrosi cistica 81
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 81
ONE-STEP DEPOSITION METHOD FOR THE SYNTHESIS OF A NANOCOMPOSITE MEMBRANE BASED ON REDUCED GRAPHENE OXIDE/ZEOLITE-A FOR ADSORPTION OF METAL IONS WITH ENHANCED ANTIBACTERIAL PROPERTIES 81
In vitro activity of multi-branched peptides against planktonic and biofilm cells of Pseudomonas aeruginosa from cystic fibrosis patients. 81
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 80
An ultrathin film membrane based on a nano-channeled reduced graphene oxide with enhanced antibacterial properties 80
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. 79
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 78
null 77
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients 76
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 76
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 75
Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? 75
Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens 74
Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients 74
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 74
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 73
Bacterial contamination of platelets and septic transfusions: review of the literature and discussion on recent patents about biofilm treatment. 72
Formazione di biofilm, diversità genetica e virulenza in Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 72
Totale 9.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.639
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021397 0 0 0 0 0 135 13 18 40 98 24 69
2021/2022828 27 39 31 121 60 22 35 62 85 20 94 232
2022/20232.073 179 270 156 248 184 384 105 152 254 25 83 33
2023/2024918 61 50 79 33 80 250 194 47 12 25 8 79
2024/20252.122 119 360 245 73 54 109 108 102 283 103 256 310
2025/20262.231 364 187 544 522 579 35 0 0 0 0 0 0
Totale 12.069